12:00 AM
 | 
May 24, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Merck regulatory update

The FDA granted marketing approval for Merck's Vioxx rofecoxib COX-2 inhibitor to treat the...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >